TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Mayne Pharma Group ( (AU:MYX) ) has shared an announcement.
Mayne Pharma Group Limited has initiated proceedings with the Takeovers Panel regarding its affairs, specifically concerning the Scheme Implementation Deed with Cosette Pharmaceuticals, Inc. The Panel has issued interim orders to amend the End Date in the Deed to 24 November 2025, preventing Cosette from terminating the agreement without prior consent. This action aims to maintain the status quo while the Panel considers the application, impacting the ongoing merger process between Mayne and Cosette.
The most recent analyst rating on (AU:MYX) stock is a Hold with a A$5.00 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.
More about Mayne Pharma Group
Average Trading Volume: 446,792
Technical Sentiment Signal: Sell
Current Market Cap: A$381.9M
For a thorough assessment of MYX stock, go to TipRanks’ Stock Analysis page.